As the results of different studies on the association of disease-related factors, such as quality of life, the use of medications, depression, etc., with BDNF levels in FM patients were controversial, further research with larger sample sizes and similar outcome measures could allow combining the results and clarify the relationship between BDNF levels and the aforementioned outcomes. This evidence concerns the gene BDNF and depressive symptom measurement.